Repurposing of Statin as an robusting approach to treat Microbial infection

Pharmacy

Drug repurposing is a cutting-edge method that can save time and money in drug development by finding novel therapeutic applications for previously accepted medications. Recently, statins, which are generally used lipid-lowering medications, have drawn interest due to their possible antibacterial potentials. The pleiotropic effects of statins, which were first created to block HMG-CoA reductase in cholesterol production, include immunomodulation and antibacterial action. According to studies, statins have antibacterial, antiviral, and antifungal potentials. They work against a variety of infections, including Candida albicans, Mycobacterium tuberculosis, and Staphylococcus aureus. It is thought that their antimicrobial effect is achieved by a variety of mechanisms, including as host immune response regulation, bacterial biofilm suppression, and membrane disruption. Additionally, statins have been demonstrated to improve the effectiveness of traditional antibiotics, indicating that combined treatment may have a synergistic impact. As antibiotic resistance are on peak, statins' potential application in antimicrobial treatment is profoundly imperative. Statins are widely accessible and have a well-established safety profile, making them a potential safer substitute for conventional antibacterial drugs. However, more clinical research is needed to identify the best dosage, effectiveness, and potential side effects while treating infectious diseases. Conclusively, using statins as antimicrobial agents is an intriguing approach to medication development. Developing new treatment approaches to treat drug-resistant illnesses might result from an understanding of their mechanisms of action and clinical application, which would eventually support international efforts to prevent antimicrobial resistance.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.